IPO Tracker

Goodwin's Capital Markets Team is one of the most innovative and active in the world. Our team of sophisticated capital markets lawyers have extensive experience across the full breadth of equity and debt capital markets, advising issuers, sponsors, underwriters and investors in a variety of transactions to ensure deals close smoothly and in a timely way.

With more than 400 lawyers located in major financial centers, we advise investment banks, issuers, and institutional investors on the full range of capital market transactions. Our team has extensive experience handling cross-border transactions, including those involving the United States, Europe, China, Canada, Australia, and Israel.

Company Name Underwriters IPO Date Offer Price to the Public Aggregate Offering Raise Original Price Range
MBX Biosciences
(NASDAQ: MBX)
J.P. Morgan Securities
Jefferies
Stifel
Guggenheim
09/12/2024
S-1
$16.00
$163.2 million
$14-$16
Zenas BioPharma
(NASDAQ: ZBIO)
Morgan Stanley
Jefferies
Citigroup Global Markets
Guggenheim
09/12/2024
S-1
$17.00
$225 million
$16-$18
Bicara Therapeutics
(NASDAQ: BCAX)
Morgan Stanley
TD Securities
Cantor Fitzgerald
Stifel
09/12/2024
S-1
$18.00
$315 million
$16-$18
OneStream, Inc. 
(NASDAQ: OS)
Morgan Stanley
J.P. Morgan Securities
KKR Capital Markets
7/23/2024
S-1
$20.00
$490 million
$17-$19
Artiva Biotherapeutics, Inc.
(NASDAQ: ARTV)
Jefferies
TD Securities
Cantor Fitzgerald
7/18/2024
S-1
$12.00
$167.04 million
$14-$16
Alumis Inc.
(NASDAQ: ALMS)
Morgan Stanley
Leerink Partners
Cantor Fitzgerald
Guggenheim
6/27/2024
S-1
$16.00
$210 million
$16-$18
Tempus AI, Inc.
(NASDAQ: TEM)
Morgan Stanley
J.P. Morgan Securities
Allen & Company
6/13/2024
S-1
$37.00
$410.7 million
$35-$37
Rapport Therapeutics
(NASDAQ: RAPP)
Goldman Sachs
Jefferies
TD Securities
Stifel
06/06/2024
S-1
$17.00 $136 million $16 – $18
Silvaco Group, Inc.
(NASDAQ: SVCO)
Jefferies
TD Securities
Craig-Hallum Capital Group
Needham & Co.
Rosenblatt Securities
05/08/2024
S-1
$19.00 $114 million $17 – $19
Rubrik, Inc.
(NASDAQ: RBRK)
Goldman Sachs
Barclays Capital
Citigroup Global Markets
Wells Fargo Securities
Guggenheim
04/24/2024
S-1
$32.00 $752 million $28 – $31
PACS Group, Inc.
(NASDAQ: PACS)
Citigroup Global Markets
J.P. Morgan Securities
Truist Securities
RBC Capital Markets
04/10/2024
S-1
$21.00 $450 million $20 – $22
Contineum Therapeutics
(NASDAQ: CTNM)
Goldman Sachs
Morgan Stanley
RBC Capital Markets
Stifel
04/04/2024
S-1
$16.00 $110 million $16 – $18
Boundless Bio
(NASDAQ: BOLD)
Goldman Sachs
Leerink
Piper Sandler
Guggenheim
03/27/2024
S-1
$16.00 $100 million $15 – $17
Metagenomi
(NASDAQ: MGX)
J.P. Morgan
BMO
Chardan
Cowen & Co.
Jefferies
Wells Fargo Securities
02/08/2024
S-1
$15.00 $93.75 million $15 – $17
Kyverna Therapeutics
(NASDAQ: KYTX)
J.P. Morgan
Morgan Stanley
Leerink
Wells Fargo Securities
02/07/2024
S-1
$22.00 $319 million $20 – $21
Fractyl Health
(NASDAQ: GUTS)
BofA Securities
Morgan Stanley
Evercore
02/01/2024
S-1
$15.00 $110 million $14 – $16
NYSE Neuroscience, Inc.
(NASDAQ: ANRO)
Jefferies
Cowen & Co.
Stifel
William Blair & Co.
02/01/2024
S-1
$16.00 $128.64 million $14 – $16
ArriVent BioPharma, Inc.
(NASDAQ: AVBP)
Goldman Sachs
Jefferies
Citigroup Global
LifeSci Capital
01/25/2024
S-1
$18.00 $175 million $17 – $19
CG Oncology
(NASDAQ: CGON)
Morgan Stanley
Cantor Fitzgerald
Goldman Sachs
LifeSci Capital
01/24/2024
S-1
$19.00 $380 million $16 – $18

Company Name Underwriters IPO Date Offer Price to the Public Aggregate Offering Raise Original Price Range
CARGO Therapeutic
(NASDAQ: CRGX)
JPM Securities
Jefferies
Cowen & Co.
Truist Securities
11/09/2023
S-1
$15.00 $281.25 million $15 – $17
Lexeo Therapeutics
(NASDAQ: LXEO)
JPM Securities
Leerink
Stifel
RBC Capital Markets
11/02/2023
S-1
$11.00 $100 million $13 – $15
Abivax SA
(NASDAQ: ABVX)
Morgan Stanley
Leerink
LifeSci Capital
RBC Capital Markets
10/19/2023
S-1
$11.60 $216.91 million $11.60 – $13
Adlai Nortye Ltd.
(NASDAQ: ANL)
Cantor Fitzgerald 09/28/2023
F-1
$23.00 $57.5 million $23 – $23
Klaviyo, Inc.
(NASDAQ: KVYO)
Goldman Sachs
Morgan Stanley
Citigroup Global Markets
Barclays Capital
09/19/2023
S-1
$30.00 $576 million $27 – $29
Neumora Therapeutics
(NASDAQ: NMRA)
JPM Securities
BofA Securities
Stifel
Guggenheim
RBC Capital Markets
William Blair & Co.
09/14/2023
S-1
$17.00 $250.7 million $16 – $18
RayzeBio, Inc.
(NASDAQ: RYZB)
JPM Securities
Jefferies
Evercore Group
Truist Securities
09/14/2023
S-1
$18.00 $311 million $16 – $18
Arm Holdings plc
(NASDAQ: ARM)
Barclays
Goldman Sachs
J.P. Morgan Securities
Mizuho Securities
09/13/2023
F-1
$51.00 $4.8 billion $47 – $51
Turnstone Biologics
(NASDAQ: TSBX)
BofA Securities
Piper Sandler
Leerink Partners
07/20/2023
S-1
$12.00 $80 million $12 – $14
Sagimet Biosciences Inc.
(NASDAQ: SGMT)
Goldman Sachs
Cowen & Co.
Piper Sandler
JPM Securities
07/13/2023
S-1
$16.00 $85 million $15 – $17
Apogee Therapeutics, Inc.
(NASDAQ: APGE)
Jefferies
Cowen & Co.
Stifel
Guggenheim
Wedbush Securities
07/13/2023
S-1
$17.00 $300.5 million $15 – $17
ACELYRIN, INC.
(NASDAQ: SLRN)
Morgan Stanley
Jefferies
Cowen & Co.
Piper Sandler
05/04/2023
S-1
$18.00 $540 million $16 – $18
Mineralys Therapeutics, Inc.
(NASDAQ: MLYS)
BofA Securities
Evercore
Stifel
Guggenheim
Credit Suisse
Wells Fargo
02/09/2023
S-1
$16.00 $192 million $14 – $16
Structure Therapeutics Inc.
(NASDAQ: GPCR)
Jefferies
SVB Securities
Guggenheim
BMO Capital Markets
02/02/2023
S-1
$15.00 $161.1 million $13 – $15

Company Name Underwriters IPO Date Offer Price to the Public Aggregate Offering Raise Original Price Range
Acrivon Therapeutics
(NASDAQ: ACRV)
Jefferies
Cowen & Co.
Piper Sandler
11/14/2022
S-1
$12.50 $94.38 million $16 – $18
Mobileye Global Inc.
(NASDAQ: MBLY)
Goldman Sachs
Morgan Stanley
10/25/2022
S-1
$21.00 $861 million $18 – $20
Prime Medicine
(NASDAQ: PRME)
JPMorgan
Goldman Sachs
Jefferies
Morgan Stanley
10/19/2022
S-1
$17.00 $175 million $16 – $18
Third Harmonic Bio
(NASDAQ: THRD)
Morgan Stanley
Jefferies
Cowen & Co.
LifeSci Capital
09/14/2022
S-1
$17.00 $185.3 million $16 – $18
PepGen Inc.
(NASDAQ: PEPG)
BofA Securities
Stifel
SVB Securities
Wedbush Securities
05/05/2022
S-1
$12.00 $108 million $13 – $15
Bausch + Lomb Corporation
(NASDAQ: BLCO)
Morgan Stanley
Goldman Sachs
Citigroup
J.P. Morgan Securities
05/05/2022
S-1
$18.00 $630 million $12 – $24
HilleVax, Inc.
(NASDAQ: HLVX)
J.P. Morgan Securities
SVB
Leerink
Stifel
Guggenheim
04/28/2022
S-1
$17.00 $200 million $16 – $18
AN2 Therapeutics
(NASDAQ: ANTX)
Oppenheimer & Co.
Cowen & Co.
SVB
Leerink
Evercore
03/24/2022
S-1
$15.00 $69 million $14 – $16
Arcellx, Inc.
(NASDAQ: ACLX)
Barclays Capital
BofA Securities
SVB
Leerink
William Blair & Co.
02/04/2022
S-1
$15.00 $142.31 million $15 – $17
Vigil Neuro
(NASDAQ: VIGL)
Morgan Stanley
Jefferies
Stifel
Guggenheim
01/11/2022
S-1
$14.00 $98 million $14 – $16
Credo Technology Group Holding Ltd
(NASDAQ: CRDO)
Goldman Sachs
BofA Securities
Cowen & Co.
Mizuho Securities
01/26/2022
S-1
$10.00 $200 million $10 – $12
Amylyx Pharmaceuticals
(NASDAQ: AMLX)
Evercore
Goldman Sachs
H.C. Wainwright
SVB
Leerink
01/07/2022
S-1
$19.00 $190 million $18 – $20
Cincor Pharma
(NASDAQ: CINC)
Evercore
Jefferies
Morgan Stanley
Oppenheimer
01/06/2022
S-1
$17.00 $193.60 million $15 – $17

Company Name Underwriters IPO Date Offer Price to the Public Aggregate Offering Raise Original Price Range
Vaxxinity
(NASDAQ: VAXX)
BofA Securities
Evercore
Jefferies
11/11/2021
S-1
$13.00 $78 million $14 – $16
IO Biotech
(NASDAQ: IOBT)
Cowen & Co.
Jefferies
Kempen & Co.
Morgan Stanley & Co.
11/04/2021
S-1
$14.00 $115.11 million $14 – $17
LianBio
(NASDAQ: LIAN)
BofA Securities
Goldman Sachs
Jefferies
Raymond James & Assoc.
11/01/2021
S-1
$16.00 $325 million $15 – $17
Aura Biosciences
(NASDAQ: AURA)
BTIG
Cowen & Co.
Evercore
SVB
Leerink
10/29/2021
S-1
$14.00 $75.60 million $14 – $16
Xilio Therapeutics
(NASDAQ: XLO)
Cowen & Co.
Guggenheim
Morgan Stanley & Co.
Raymond James & Assoc.
10/22/2021
S-1
$16.00 S117.65 million $16 – $18
Ventyx Biosciences, Inc.
(NASDAQ: VTYX)
Evercore
Jefferies
LifeSci Capital
Piper Sandler
10/20/2021
S-1
$16.00 $174.30 million $15 – $17
Pyxis Oncology
(NASDAQ: PYXS)
BofA Securities
Credit Suisse
Jefferies
LifeSci Capital
William Blair & Co.
10/07/2021
S-1
$16.00 $168 million $14 – $16
Theseus Pharmaceuticals, Inc.
(NASDAQ: THRX)
SVB
Leerink
Cantor Fitzgerald
Jefferies
Wedbush Securities
10/06/2021
S-1
$16.00 $160 million $14 – $16
DICE Therapeutics
(NASDAQ: DICE)
SVB
Leerink
Evercore
BofA Securities
09/14/2021
S-1
$17.00 $204 million $15 – $17
Eliem Therapeutics
(NASDAQ: ELYM)
SVB
Leerink
Evercore
Stifel Nicolaus
Guggenheim
08/09/2021
S-1
$12.50 $92 million $17 – $19
Adagio Therapeutics
(NASDAQ: ADGI)
Morgan Stanley
Jefferies
Stifel Nicolaus
Guggenheim
08/05/2021
S-1
$17.00 $355.8 million $16 – $18
Rani Therapeutics
(NASDAQ: RANI)
BofA Securities
Stifel Nicolaus
Cantor Fitzgerald
Canaccord Genuity
07/30/2021
S-1
$11.00 $73.3 million $14 – $16
Immuneering
(NASDAQ: IMRX)
Morgan Stanley
Jefferies
Cowen & Co.
Guggenheim
07/30/2021
S-1
$15.00 $129.4 million $14 – $16
Omega Therapeutics
(NASDAQ: OMGA)
Goldman Sachs
Jefferies
Piper Sandler
07/30/2021
S-1
$17.00 $125.8 million $16 – $18
Tenaya Therapeutics
(NASDAQ: TNYA)
Morgan Stanley
Cowen & Co.
Piper Sandler
07/30/2021
S-1
$15.00 $207 million $14 – $16
Nuvalent
(NASDAQ: NUVL)
Jefferies
SVB Securities
Guggenheim
BMO Capital Markets
07/28/2021
S-1
$17.00 $190.6 million $16 – $18
Icosavax
(NASDAQ: ICVX)
Jefferies
Cowen
Evercore
William Blair
07/28/2021
S-1
$15.00 $209.3 million $14 – $16
Rallybio
(NASDAQ: RLYB)
Jefferies
Cowen
Evercore
07/28/2021
S-1
$13.00 $92.7 million $13 – $15
Candel Therapeutics
(NASDAQ: CADL)
Jefferies
Credit Suisse
BMO Capital Markets
UBS
07/26/2021
S-1
$8.00 $72 million $13 – $15
Caribou Biosciences
(NASDAQ: CRBU)
BofA Securities
Citigroup
SVB
Leerink
07/22/2021
S-1
$16.00 $304 million $14 – $16
HCW Biologics
(NASDAQ: HCWB)
Jefferies
SVB Securities
Guggenheim
BMO Capital Markets
07/19/2021
S-1
$8.00 $56 million $8 – $10
Imago BioSciences
(NASDAQ: IMGO)
Jefferies
Cowen & Co.
Stifel Nicolaus
Guggenheim
07/15/2021
S-1
$16.00 $134.4 million $14 – $16
TScan Therapeutics
(NASDAQ: TCRX)
Morgan Stanley
Jefferies
Cowen & Co.
Barclays Capital
07/15/2021
S-1
$15.00 $100 million $15 – $17
Erasca
(NASDAQ: ERAS)
J.P. Morgan
Morgan Stanley
BofA Securities
Evercore
Guggenheim
07/15/2021
S-1
$16.00 $345 million $14 – $16
Acumen Pharmaceuticals
(NASDAQ: ABOS)
BofA Securities
Credit Suisse
Stifel Nicolaus
UBS
06/30/2021
S-1
$16.00 $160 million $14 – $16
Aerovate Therapeutics
(NASDAQ: AVTE)
Jefferies
Cowen & Co.
Evercore
Wedbush PacGrow
06/29/2021
S-1
$14.00 $139.8 million $13 – $15
GH Research
(NASDAQ: GHRS)
Cowen & Co.
Stifel Nicolaus
Canaccord Genuity
JMP Securities
06/24/2021
F-1
$16.00 $160 million $14 – $16
Graphite Bio
(NASDAQ: GRPH)
Morgan Stanley
BofA Securities
Cowen & Co.
SVB
Leerink
06/24/2021
S-1
$17.00 $273.7 million $15 – $17
Elevation Oncology
(NASDAQ: ELEV)
J.P. Morgan
Cowen & Co.
SVB
Leerink
Wedbush PacGrow
06/24/2021
S-1
$16.00 $100 million $15 – $17
Monte Rosa Therapeutics
(NASDAQ: GLUE)
J.P. Morgan
Cowen & Co.
Piper Sandler
Guggenheim
06/23/2021
S-1
$19.00 $222.3 million $17 – $19
Ambrx Biopharma
(NASDAQ: AMAM)
Goldman Sachs
BofA Securities
Cowen & Co.
06/17/2021
S-1
$18.00 $126 million $17 – $19
atai Life Sciences
(NASDAQ: ATAI)
Credit Suisse
Citigroup
Cowen & Co.
Berenberg Capital Markets
Cantor Fitzgerald
RBC Capital Markets
Canaccord Genuity
06/17/2021
S-1
$15.00 $225 million $13 – $15
Cyteir Therapeutics
(NASDAQ: CYT)
J.P. Morgan
Morgan Stanley
BofA Securities
Wedbush PacGrow
06/17/2021
S-1
$18.00 $133.3 million $16 – $18
Century Therapeutics
(NASDAQ: IPSC)
J.P. Morgan
BofA Securities
SVB
Leerink
Piper Sandler
06/17/2021
S-1
$20.00 $242.7 million $18 – $20
Lyell Immunopharma
(NASDAQ: LYEL)
Goldman Sachs
BofA Securities
J.P. Morgan
Morgan Stanley
06/16/2021
S-1
$17.00 $425 million $16 – $18
Verve Therapeutics
(NASDAQ: VERV)
J.P. Morgan
Jefferies
Guggenheim
William Blair
06/16/2021
S-1
$19.00 $306.7 million $16 – $18
Molecular Partners
(NASDAQ: MOLN)
J.P. Morgan
SVB
Leerink
Cowen & Co.
RBC Capital Markets
Kempen & Co.
06/15/2021
S-1
$21.25 $63.8 million $27.14
Janux Therapeutics
(NASDAQ: JANX)
BofA Securities
Cowen & Co.
Evercore
H.C. Wainwright
06/10/2021
S-1
$17.00 $222.9 million $15 – $17
Centessa Pharmaceuticals
(NASDAQ: CNTA)
Morgan Stanley
Goldman Sachs
Jefferies
Evercore
05/27/2021
S-1
$20.00 $379.5 million $18 – $20
Day One Biopharmaceuticals
(NASDAQ: DAWN)
J.P. Morgan
Cowen & Co.
Piper Sandler
Wedbush PacGrow
05/26/2021
S-1
$16.00 $184 million $14 – $16
Talaris Therapeutics
(NASDAQ: TALS)
Morgan Stanley
SVB
Leerink
Evercore
Guggenheim
05/06/2021
S-1
$17.00 $150 million $16 – $18
Valneva
(NASDAQ: VALN)
Goldman Sachs
Jefferies
Guggenheim
Bryan, Garnier & Co.
05/06/2021
F-1
$26.41 $107.6 million $24.04 – $28.85
Werewolf Therapeutics
(NASDAQ: HOWL)
Jefferies
SVB
Leerink
Evercore
H.C. Wainwright
04/29/2021
S-1
$16.00 $120 million $15 – $17
Vaccitech
(NASDAQ: VACC)
Morgan Stanley
Jefferies
Barclays
William Blair
H.C. Wainwright
04/29/2021
S-1
$17.00 $110.5 million $16 – $18
Impel NeuroPharma
(NASDAQ: IMPL)
Cowen & Co.
Guggenheim
Wedbush PacGrow
04/22/2021
S-1
$15.00 $80 million $14 – $16
Rain Therapeutics
(NASDAQ: RAIN)
Goldman Sachs
Citigroup
Piper Sandler
Guggenheim
04/22/2021
S-1
$17.00 $125 million $16 – $18
Biomea Fusion
(NASDAQ: BMEA)
J.P. Morgan
Jefferies
Piper Sandler
04/15/2021
S-1
$17.00 $153 million $15 – $17
Recursion Pharmaceuticals
(NASDAQ: RXRX)
Goldman Sachs
J.P. Morgan
BofA Securities
SVB
Leerink
Allen & Company
KeyBanc Capital Markets
04/15/2021
S-1
$18.00 $501.8 million $16 – $18
Reneo Pharmaceuticals
(NASDAQ: RPHM)
Jefferies
SVB
Leerink
Piper Sandler
04/08/2021
S-1
$15.00 $93.8 million $15 – $17
VectivBio
(NASDAQ: VECT)
BofA Securities
SVB
Leerink
Credit Suisse
LifeSci Capital
04/08/2021
S-1
$17.00 $146.6 million $16 – $18
Achilles Therapeutics
(NASDAQ: ACHL)
J.P. Morgan
BofA Securities
Piper Sandler
Chardan Capital Markets
Oppenheimer
Kempen & Co
03/30/2021
F-1
$18.00 $175.5 million $17 – $19
Design Therapeutics
(NASDAQ: DSGN)
Goldman Sachs
SVB
Leerink
Piper Sandler
03/25/2021
S-1
$20.00 $276 million $18 – $20
Edgewise Therapeutics
(NASDAQ: EWTX)
J.P. Morgan
Goldman Sachs
SVB
Leerink
03/25/2021
S-1
$16.00 $202.4 million $14 – $16
Ikena Oncology
(NASDAQ: IKNA)
Jefferies
Cowen & Co.
Credit Suisse
William Blair
03/25/2021
S-1
$16.00 $143.8 million $15 – $17
LAVA Therapeutics
(NASDAQ: LVTX)
J.P. Morgan
Jefferies
SVB
Leerink
03/24/2021
F-1
$15.00 $100.5 million $14 – $16
Connect Biopharma
(NASDAQ: CNTB)
Jefferies
SVB
Leerink
Piper Sandler
China International Capital Corporation
03/18/2021
F-1
$17.00 $219.9 million $15 – $17
Instil Bio
(NASDAQ: TIL)
Morgan Stanley
Jefferies
Cowen & Co.
03/18/2021
S-1
$20.00 $368 million $17 – $19
Finch Therapeutics
(NASDAQ: FNCH)
BofA Securities
Jefferies
Evercore
03/18/2021
S-1
$17.00 $127.5 million $15 – $17
Prometheus Biosciences
(NASDAQ: RXDX)
SVB
Leerink
Credit Suisse
Stifel Nicolaus
Guggenheim
03/11/2021
S-1
$19.00 $218.5 million $16 – $18
Longboard Pharmaceuticals
(NASDAQ: LBPH)
Citigroup
Evercore
Guggenheim
Cantor Fitzgerald
03/11/2021
S-1
$16.00 $80 million $14 – $16
NexImmune
(NASDAQ: NEXI)
Barclays Capital
Cantor Fitzgerald
Raymond James
Allen & Company
02/11/2021
S-1
$17.00 $126.5 million $15 – $17
Decibel Therapeutics
(NASDAQ: DBTX)
Citigroup
SVB
Leerink
BMO Capital Markets
Barclays Capital
02/11/2021
S-1
$18.00 $127 million $16 – $18
Adagene
(NASDAQ: ADAG)
Goldman Sachs (Asia)
Morgan Stanley
Jefferies
China Renaissance Securities (Hong Kong)
02/08/2021
F-1
$19.00 $161 million $17 – $19
Vor Biopharma
(NASDAQ: VOR)
Goldman Sachs
Evercore
Barclays Capital
Stifel Nicolaus
02/05/2021
S-1
$18.00 $203.4 million $16 – $18
Angion Biomedica
(NASDAQ: ANGN)
Cowen & Co.
Stifel Nicolaus
H.C. Wainwright
Oppenheimer
02/04/2021
S-1
$16.00 $92 million $14 – $16
Bolt Biotherapeutics
(NASDAQ: BOLT)
Morgan Stanley
SVB
Leerink
Stifel Nicolaus
Guggenheim
02/04/2021
S-1
$20.00 $264.5 million $16 – $18
Immunocore
(NASDAQ: IMCR)
Goldman Sachs
J.P. Morgan
Jefferies
02/04/2021
F-1
$26.00 $297.1 million $23 – $25
Pharvaris
(NASDAQ: PHVS)
Morgan Stanley
BofA Securities
Sunrise Securities
Oppenheimer
Kempen & Co
02/04/2021
F-1
$20.00 $190.2 million $17 – $19
Terns Pharmaceuticals
(NASDAQ: TERN)
J.P. Morgan
Goldman Sachs
Cowen & Co.
02/04/2021
S-1
$17.00 $146.6 million $15 – $17
Sensei Biotherapeutics
(NASDAQ: SNSE)
Citigroup
Piper Sandler
Berenberg Capital Markets
Oppenheimer
02/03/2021
S-1
$19.00 $152.6 million $16 – $18
Landos Biopharma
(NASDAQ: LABP)
J.P. Morgan
Jefferies
SVB
Leerink
Raymond James
02/03/2021
S-1
$16.00 $100 million $15 – $17
Sana Biotechnology
(NASDAQ: SANA)
Morgan Stanley
Goldman Sachs
J.P. Morgan
BofA Securities
02/03/2021
S-1
$25.00 $675.6 million $20 – $23
Cullinan Management
(NASDAQ: CGEM)
Morgan Stanley
SVB
Leerink
Evercore
H.C. Wainwright
01/07/2021
S-1
$21.00 $287.4 million $17 – $19
Gracell Biotechnologies
(NASDAQ: GRCL)
Citigroup
Jefferies
Piper Sandler
Wells Fargo
01/07/2021
F-1
$19.00 $209 million $16 – $18

Company Name Underwriters IPO Date Offer Price to the Public Aggregate Offering Raise Original Price Range
BioAtla
(NASDAQ: BCAB)
J.P. Morgan
Jefferies
Credit Suisse
12/15/2020
S-1
$18.00 $217.4 million $15 – $17
AbCellera Biologics
(NASDAQ: ABCL)
Credit Suisse
Stifel Nicolaus
Berenberg Capital Markets
SVB
Leerink
BMO Capital Markets
12/10/2020
S-1
$20.00 $555.5 million $14 – $17
4D Molecular Therapeutics
(NASDAQ: FDMT)
Goldman Sachs
BofA Securities
Evercore
12/10/2020
S-1
$23.00 $222 million $20 – $22
Nanobiotix
(NASDAQ: NBTX)
Jefferies
Evercore
UBS
12/10/2020
F-1
$11.14 $100.4 million $14.69
Seer
(NASDAQ: SEER)
J.P. Morgan
Morgan Stanley
BofA Securities
Cowen & Co.
12/03/2020
S-1
$19.00 $201.3 million $16 – $18
Sigilon Therapeutics
(NASDAQ: SGTX)
Morgan Stanley
Jefferies
Barclays Capital
Canaccord Genuity
12/03/2020
S-1
$18.00 $144.9 million $17 – $19
Silverback Therapeutics
(NASDAQ: SBTX)
Goldman Sachs
SVB
Leerink
Stifel Nicolaus
12/03/2020
S-1
$21.00 $277.7 million $17 – $19
Kinnate Biopharma
(NASDAQ: KNTE)
Goldman Sachs
SVB
Leerink
Piper Sandler
12/02/2020
S-1
$20.00 $276 million $16 – $18
Maravai LifeSciences
(NASDAQ: MRVI)
Morgan Stanley
Jefferies
Goldman Sachs
11/19/2020
S-1
$27.00 $1.86 billion $24 – $27
Olema Pharmaceuticals
(NASDAQ: OLMA)
J.P. Morgan
Jefferies
Cowen & Co.
Canaccord Genuity
11/18/2020
S-1
$19.00 $240.4 million $16 – $18
Atea Pharmaceuticals
(NASDAQ: AVIR)
J.P. Morgan
Morgan Stanley
Evercore
William Blair
10/29/2020
S-1
$24.00 $345 million $22 – $24
SQZ Biotechnologies
(NASDAQ: SQZ)
BofA Securities
Evercore
Stifel Nicolaus
BTIG
10/29/2020
S-1
$16.00 $81 million $16 – $18
Galecto
(NASDAQ: GLTO)
BofA Securities
SVB
Leerink
Credit Suisse
10/28/2020
S-1
$15.00 $85 million $14 – $16
Foghorn Therapeutics
(NASDAQ: FHTX)
Goldman Sachs
Morgan Stanley
Cowen & Co.
10/22/2020
S-1
$16.00 $120 million $15 – $17
Abcam
(NASDAQ: ABCM)
Morgan Stanley
BofA Securities
SVB
Leerink
Lazard Freres
William Blair
10/21/2020
F-1
$17.50 $180 million $16.52
Opthea
(NASDAQ: OPT)
Citigroup
SVB
Leerink
Oppenheimer
Truist Securities
10/16/2020
F-1
$13.50 $128.2 million $17.26
Aligos Therapeutics
(NASDAQ: ALGS)
J.P. Morgan
Jefferies
Piper Sandler
Cantor Fitzgerald
10/15/2020
S-1
$15.00 $150 million $15 – $16
Praxis Precision Medicines
(NASDAQ: PRAX)
Cowen & Co.
Evercore
Piper Sandler
Wedbush PacGrow
10/15/2020
S-1
$19.00 $218.5 million $16 – $18
Codiak Biosciences
(NASDAQ: CDAK)
Goldman Sachs
Evercore
William Blair
Wedbush PacGrow
10/13/2020
S-1
$15.00 $82.5 million $14 – $16
Kronos Bio
(NASDAQ: KRON)
Goldman Sachs
Jefferies
Cowen & Co.
Piper Sandler
10/08/2020
S-1
$19.00 $287.5 million $16 – $18
Shattuck Labs
(NASDAQ: STTK)
Citigroup
Cowen & Co.
Evercore
Needham
10/08/2020
S-1
$17.00 $232.3 million $14 – $16
Spruce Biosciences
(NASDAQ: SPRB)
Cowen & Co.
SVB
Leerink
Credit Suisse
RBC Capital Markets
10/08/2020
S-1
$15.00 $103.5 million $14 – $16
Aziyo Biologics
(NASDAQ: AZYO)
Piper Sandler
Cowen & Co.
Cantor Fitzgerald
Truist Securities
10/07/2020
S-1
$17.00 $50 million $16 – $18
C4 Therapeutics
(NASDAQ: CCCC)
Jefferies
Evercore
BMO Capital Markets
UBS
10/01/2020
S-1
$19.00 $209.76 million $16 – $18
Immunome
(NASDAQ: IMNM)
Ladenburg Thalmann
Chardan Capital Markets
10/01/2020
S-1
$12.00 $44.85 million $11 – $13
Oncorus
(NASDAQ: ONCR)
Jefferies
Evercore
Piper Sandler
10/01/2020
S-1
$15.00 $87 million $14 – $16
Orphazyme
(NASDAQ: ORPH)
BofA Securities
Cowen & Co.
Guggenheim
Danske Markets
09/28/2020
F-1
$11.00 $50.17 million $13.13
Graybug Vision
(NASDAQ: GRAY)
SVB
Leerink
Piper Sandler
09/24/2020
S-1
$16.00 $90 million $15 – $17
PMV Pharmaceuticals
(NASDAQ: PMVP)
Goldman Sachs
BofA Securities
Cowen & Co.
Evercore
09/24/2020
S-1
$18.00 $243.53 million $16 – $18
Prelude Therapeutics
(NASDAQ: PRLD)
Morgan Stanley
Goldman Sachs
BofA Securities
09/24/2020
S-1
$19.00 $181.90 million $17 – $19
Taysha Gene Therapies
(NASDAQ: TSHA)
Goldman Sachs
Morgan Stanley
Jefferies
09/23/2020
S-1
$20.00 $181 million $18 – $20
Athira Pharma
(NASDAQ: ATHA)
Goldman Sachs
Jefferies
Stifel Nicolaus
09/17/2020
S-1
$17.00 $204 million $15 – $17
COMPASS Pathways
(NASDAQ: CMPS)
Cowen & Co.
Evercore
Berenberg Capital Markets
09/17/2020
F-1
$17.00 $146.60 million $14 – $16
Dyne Therapeutics
(NASDAQ: DYN)
J.P. Morgan
Jefferies
Piper Sandler
Stifel Nicolaus
09/16/2020
S-1
$19.00 $268 million $16 – $18
Metacrine
(NASDAQ: MTCR)
Jefferies
Evercore
RBC Capital Markets
Canaccord Genuity
09/15/2020
S-1
$13.00 $85.02 million $12 – $14
Kymera Therapeutics
(NASDAQ: KYMR)
Morgan Stanley
BofA Securities
Cowen & Co.
Guggenheim
08/20/2020
S-1
$20.00 $199.75 million $16 – $18
Harmony Biosciences
(NASDAQ: HRMY)
Goldman Sachs
Jefferies
Piper Sandler
08/18/2020
S-1
$24.00 $147.62 million $20 – $23
Inhibrx
(NASDAQ: INBX)
Jefferies
Evercore
Credit Suisse
08/18/2020
S-1
$17.00 $136.85 million $16 – $18
CureVac
(NASDAQ: CVAC)
BofA Securities
Jefferies
Credit Suisse
08/13/2020
F-1
$16.00 $245.33 million $14 – $16
Checkmate Pharmaceuticals
(NASDAQ: CMPI)
BofA Securities
Jefferies
BMO Capital Markets
08/06/2020
S-1
$15.00 $75 million $14 – $16
Freeline Therapeutics
(NASDAQ: FRLN)
J.P. Morgan
Morgan Stanley
Evercore
08/06/2020
F-1
$18.00 $158.82 million $16 – $18
Acutus Medical
(NASDAQ: AFIB)
J.P. Morgan
BofA Securities
William Blair
08/05/2020
S-1
$18.00 $182.64 million $16 – $18
Oak Street Health
(NASDAQ: OSH)
J.P. Morgan
Goldman Sachs
Morgan Stanley
08/05/2020
S-1
$21.00 $377.34 million $15 – $17
AlloVir
(NASDAQ: ALVR)
Morgan Stanley
J.P. Morgan
SVB
Leerink
Piper Sandler
07/29/2020
S-1
$17.00 $317.68 million $16 – $18
Annexon
(NASDAQ: ANNX)
J.P. Morgan
BofA Securities
Cowen & Co.
07/23/2020
S-1
$17 $288.36 million $14 – $16
Inozyme Pharma
(NASDAQ: INZY)
BofA Securities
Cowen & Co.
Piper Sandler
07/23/2020
S-1
$16.00 $128.8 million $14 – $16
iTeos Therapeutics
(NASDAQ: ITOS)
J.P. Morgan
SVB
Leerink
Piper Sandler
07/23/2020
S-1
$19.00 $231.31 million $16 – $18
Nurix Therapeutics
(NASDAQ: NRIX)
J.P. Morgan
Piper Sandler
Stifel Nicolaus
07/23/2020
S-1
$19.00 $240.35 million $16 – $18
ALX Oncology
(NASDAQ: ALXO)
Jefferies
Credit Suisse
Piper Sandler
Cantor Fitzgerald
07/16/2020
S-1
$19.00 $185.7 million $15 – $17
Berkeley Lights
(NASDAQ: BLI)
J.P. Morgan
Morgan Stanley
Cowen & Co.
07/16/2020
S-1
$22.00 $204.9 million $16 – $18
Pandion Therapeutics
(NASDAQ: PAND)
Goldman Sachs
Morgan Stanley
SVB
Leerink
BMO Capital Markets
07/16/2020
S-1
$18.00 $135 million $16 – $18
Renalytix AI
(NASDAQ: RNLX)
J.P. Morgan
Sitfel Nicolaus
07/16/2020
F-1
$13.50 $85.1 million $14.22
Relay Therapeutics
(NASDAQ: RLAY)
J.P. Morgan
Goldman Sachs
Cowen & Co.
Guggenheim
07/15/2020
S-1
$20.00 $460 million $16 – $18
Inventiva
(NASDAQ: IVA)
Jefferies
Stifel Nicolaus
Guggenheim
07/09/2020
F-1
$14.40 $123.8 million $13.68
NKarta
(NASDAQ: NKTX)
Cowen & Co.
Evercore
Stifel Nicolaus
Mizuho
07/09/2020
S-1
$18.00 $289.8 million $14 – $16
Poseida Therapeutics
(NASDAQ: PSTX)
BofA Securities
Piper Sandler
William Blair
07/09/2020
S-1
$16.00 $257.6 million $14 – $16
Akouos, Inc.
(NASDAQ: AKUS)
BofA Securities
Cowen & Co.
Piper Sandler
06/25/2020
S-1
$17.00 $244.37 million $14 – $16
Forma Therapeutics Holdings, Inc.
(NASDAQ: FMTX)
Jefferies
SVB
Leerink
Credit Suisse
06/25/2020
S-1
$20.00 $319.29 million $16 – $18
PolyPid Ltd.
(NASDAQ: PYPD)
Barclays Capital
BMO Capital Markets
Raymond James
06/25/2020
F-1
$16.00 $69.00 million $15 – $17
Progenity, Inc.
(NASDAQ: PROG)
Piper Sandler
Wells Fargo Securities
06/19/2020
S-1
$15.00 $115 million $14 – $16
Repare Therapeutics Inc.
(NASDAQ: RPTX)
Morgan Stanley
Goldman Sachs
Cowen & Co.
Piper Sandler
06/18/2020
S-1
$20.00 $253.00 million $16 – $18
Genetron Holdings Limited
(NASDAQ: GTH)
Credit Suisse
China International Capital Corporation
06/18/2020
F-1
$16.00 $294.4 million $11.50 – $13.50
Royalty Pharma plc
(NASDAQ: RPRX)
J.P. Morgan
Morgan Stanley
BofA Securities
Goldman Sachs
Citigroup
UBS Securities
06/15/2020
S-1
$28.00 $2.5 billion $25 – $28
Avidity Biosciences, Inc.
(NASDAQ: RNA)
Cowen & Co.
SVB
Leerink
Credit Suisse
Wells Fargo Securities
06/11/2020
S-1
$18.00 $298.08 million $14 – $16
Burning Rock Biotech Limited
(NASDAQ: BNR)
Morgan Stanley
BofA Securities
Cowen & Co.
06/11/2020
F-1
$16.50 $256.16 million $13.50 – $15.50
Generation Bio Co.
(NASDAQ: GBIO)
J.P. Morgan
Jefferies
Cowen & Co.
Wedbush Securities
06/11/2020
S-1
$19.00 $229.99 million $16 – $18
Vaxcyte, Inc.
(NASDAQ: PCVX)
BofA Securities
Jefferies
Evercore
06/11/2020
S-1
$16.00 $287.50 million $14 – $16
Fusion Pharmaceuticals Inc.
(NASDAQ: FUSN)
Morgan Stanley
Jefferies
Cowen & Co.
06/05/2020
S-1
$17.00 $244.37 million $14 – $16
Legend Biotech Corporation
(NASDAQ: LEGN)
Morgan Stanley
J.P. Morgan
Jefferies
06/05/2020
F-1
$23.00 $487.34 million $18 – $20
Applied Molecular Transport Inc.
(NASDAQ: AMTI)
BofA Securities
Jefferies
SVB
Leerink
06/04/2020
S-1
$14.00 $177.10 million $12 – $14
Calliditas Therapeutics
(NASDAQ: CALT)
Citigroup
Jefferies
Stifel Nicolaus
06/04/2020
F-1
$19.50 $90.00 million $19.77
Pliant Therapeutics, Inc.
(NASDAQ: PLRX)
Citigroup
Cowen & Co.
Piper Sandler
06/02/2020
S-1
$16.00 $165.60 million $14 – $16
Inari Medical, Inc.
(NASDAQ: NARI)
BofA Securities
Morgan Stanley
05/21/2020
S-1
$19.00 $179.22 million $14 – $16
ADC Therapeutics SA
(NASDAQ: ADCT)
Morgan Stanley
BofA Securities
Cowen & Co.
05/14/2020
F-1
$19.00 $267.56 million $16 – $18
Ayala Pharmaceuticals, Inc.
(NASDAQ: AYLA)
Citigroup
Jefferies
05/07/2020
S-1
$15.00 $63.25 million $14 – $16
Lyra Therapeutics, Inc.
(NASDAQ: LYRA)
BofA Securities
Jefferies
William Blair
04/30/2020
S-1
$16.00 $64.40 million $14 – $16
ORIC Pharmaceuticals, Inc.
(NASDAQ: ORIC)
J.P. Morgan
Citigroup
Jefferies
Guggenheim
04/23/2020
S-1
$16.00 $138 million $14 – $16
Keros Therapeutics, Inc.
(NASDAQ: KROS)
Jefferies
SVB
Leerink
Piper Sandler
04/07/2020
S-1
$16.00 $110.40 million $14 – $16
Zentalis Pharmaceuticals, Inc.
(NASDAQ: ZNTL)
Morgan Stanley
Jefferies
SVB
Leerink
Guggenheim
04/02/2020
S-1
$18.00 $190.02 million $16 – $18
IMARA Inc.
(NASDAQ: IMRA)
Morgan Stanley
Citigroup
SVB
Leerink
03/11/2020
S-1
$16.00 $86.48 million $16 – $18
Passage Bio, Inc.
(NASDAQ: PASG)
J.P. Morgan
Goldman Sachs
Cowen & Co.
02/27/2020
S-1
$18.00 $248.4 million $16 – $18
Revolution Medicines, Inc.
(NASDAQ: RVMD)
J.P. Morgan
Cowen & Co.
SVB
Leerink
Guggenheim
02/12/2020
S-1
$17.00 $273.7 million $14 – $16
Beam Therapeutics, Inc.
(NASDAQ: BEAM)
J.P. Morgan
Jefferies
Barclays Capital
02/05/2020
S-1
$17.00 $207 million $15 – $17
PPD, Inc.
(NASDAQ: PPD)
Barclays Capital
J.P. Morgan
Morgan Stanley
Goldman Sachs
02/05/2020
S-1
$27.00 $1.80 billion $24 – $27
1Life Healthcare
(NASDAQ: ONEM)
J.P. Morgan
Morgan Stanley
01/30/2020
S-1
$14.00 $281 million $14 – $16
Arcutis Biotherapeutics, Inc.
(NASDAQ: ARQT)
Goldman Sachs
Cowen & Co.
Guggenheim
01/30/2020
S-1
$17.00 $183.28 million $15 – $17
Black Diamond Therapeutics
(NASDAQ: BDTX)
J.P. Morgan
Jefferies
Cowen & Co.
01/29/2020
S-1
$19.00 $231.3 million $16 – $18
I-Mab
(NASDAQ: IMAB)
Jefferies
China International Capital Corporation
01/16/2020
F-1
$14.00 $119.25 million $12 – $15